Cargando…

Gut Microbiota Interventions With Clostridium butyricum and Norfloxacin Modulate Immune Response in Experimental Autoimmune Encephalomyelitis Mice

Gut microbiota has been proposed as an important environmental factor which can intervene and modulate central nervous system autoimmunity. Here, we altered the composition of gut flora with Clostridium butyricum and norfloxacin in experimental autoimmune encephalomyelitis (EAE), an animal model of...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hao, Ma, Xiaomeng, Liu, Yingying, Ma, Lili, Chen, Zhaoyu, Lin, Xiuli, Si, Lei, Ma, Xueying, Chen, Xiaohong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689973/
https://www.ncbi.nlm.nih.gov/pubmed/31428083
http://dx.doi.org/10.3389/fimmu.2019.01662
_version_ 1783443122879987712
author Chen, Hao
Ma, Xiaomeng
Liu, Yingying
Ma, Lili
Chen, Zhaoyu
Lin, Xiuli
Si, Lei
Ma, Xueying
Chen, Xiaohong
author_facet Chen, Hao
Ma, Xiaomeng
Liu, Yingying
Ma, Lili
Chen, Zhaoyu
Lin, Xiuli
Si, Lei
Ma, Xueying
Chen, Xiaohong
author_sort Chen, Hao
collection PubMed
description Gut microbiota has been proposed as an important environmental factor which can intervene and modulate central nervous system autoimmunity. Here, we altered the composition of gut flora with Clostridium butyricum and norfloxacin in experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis. We found that appropriate C. butyricum (5.0 × 10(6) CFU/mL intragastrically daily, staring at weaning period of age) and norfloxacin (5 mg/kg intragastrically daily, 1 week prior to EAE induction) treatment could both ameliorate EAE although there are obvious differences in gut microbiota composition between these two interventions. C. butyricum increased while norfloxacin decreased the abundance and diversity of the gut microbiota in EAE mice, and both of the treatments decreased firmicutes/bacteroidetes ratio. In the genus level, C. butyricum treatment increased the abundance of Prevotella while Akkermansia and Allobaculum increased in norfloxacin treatment. Moreover, both interventions reduced Desulfovibroneceae and Ruminococcus species. Although there was discrepancy in the gut microbiota composition with the two interventions, C. butyricum and norfloxacin treatment both reduced Th17 response and increased Treg response in the gastrointestinal tract and extra-gastrointestinal organ systems in EAE mice. And the reduced activity of p38 mitogen-activated kinase and c-Jun N-terminal kinase signaling in spinal cord could be observed in the two interventions. The results suggested that manipulation of gut microbiota interventions should take factors such as timing, duration, and dosage into consideration. The discrepancy in the gut microbiota composition and the similar protective T cells response of C. butyricum and norfloxacin implies that achieving intestinal microecology balance by promoting and/or inhibiting the gut microbiota contribute to the well-being of immune response in EAE mice.
format Online
Article
Text
id pubmed-6689973
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-66899732019-08-19 Gut Microbiota Interventions With Clostridium butyricum and Norfloxacin Modulate Immune Response in Experimental Autoimmune Encephalomyelitis Mice Chen, Hao Ma, Xiaomeng Liu, Yingying Ma, Lili Chen, Zhaoyu Lin, Xiuli Si, Lei Ma, Xueying Chen, Xiaohong Front Immunol Immunology Gut microbiota has been proposed as an important environmental factor which can intervene and modulate central nervous system autoimmunity. Here, we altered the composition of gut flora with Clostridium butyricum and norfloxacin in experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis. We found that appropriate C. butyricum (5.0 × 10(6) CFU/mL intragastrically daily, staring at weaning period of age) and norfloxacin (5 mg/kg intragastrically daily, 1 week prior to EAE induction) treatment could both ameliorate EAE although there are obvious differences in gut microbiota composition between these two interventions. C. butyricum increased while norfloxacin decreased the abundance and diversity of the gut microbiota in EAE mice, and both of the treatments decreased firmicutes/bacteroidetes ratio. In the genus level, C. butyricum treatment increased the abundance of Prevotella while Akkermansia and Allobaculum increased in norfloxacin treatment. Moreover, both interventions reduced Desulfovibroneceae and Ruminococcus species. Although there was discrepancy in the gut microbiota composition with the two interventions, C. butyricum and norfloxacin treatment both reduced Th17 response and increased Treg response in the gastrointestinal tract and extra-gastrointestinal organ systems in EAE mice. And the reduced activity of p38 mitogen-activated kinase and c-Jun N-terminal kinase signaling in spinal cord could be observed in the two interventions. The results suggested that manipulation of gut microbiota interventions should take factors such as timing, duration, and dosage into consideration. The discrepancy in the gut microbiota composition and the similar protective T cells response of C. butyricum and norfloxacin implies that achieving intestinal microecology balance by promoting and/or inhibiting the gut microbiota contribute to the well-being of immune response in EAE mice. Frontiers Media S.A. 2019-07-23 /pmc/articles/PMC6689973/ /pubmed/31428083 http://dx.doi.org/10.3389/fimmu.2019.01662 Text en Copyright © 2019 Chen, Ma, Liu, Ma, Chen, Lin, Si, Ma and Chen. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Chen, Hao
Ma, Xiaomeng
Liu, Yingying
Ma, Lili
Chen, Zhaoyu
Lin, Xiuli
Si, Lei
Ma, Xueying
Chen, Xiaohong
Gut Microbiota Interventions With Clostridium butyricum and Norfloxacin Modulate Immune Response in Experimental Autoimmune Encephalomyelitis Mice
title Gut Microbiota Interventions With Clostridium butyricum and Norfloxacin Modulate Immune Response in Experimental Autoimmune Encephalomyelitis Mice
title_full Gut Microbiota Interventions With Clostridium butyricum and Norfloxacin Modulate Immune Response in Experimental Autoimmune Encephalomyelitis Mice
title_fullStr Gut Microbiota Interventions With Clostridium butyricum and Norfloxacin Modulate Immune Response in Experimental Autoimmune Encephalomyelitis Mice
title_full_unstemmed Gut Microbiota Interventions With Clostridium butyricum and Norfloxacin Modulate Immune Response in Experimental Autoimmune Encephalomyelitis Mice
title_short Gut Microbiota Interventions With Clostridium butyricum and Norfloxacin Modulate Immune Response in Experimental Autoimmune Encephalomyelitis Mice
title_sort gut microbiota interventions with clostridium butyricum and norfloxacin modulate immune response in experimental autoimmune encephalomyelitis mice
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689973/
https://www.ncbi.nlm.nih.gov/pubmed/31428083
http://dx.doi.org/10.3389/fimmu.2019.01662
work_keys_str_mv AT chenhao gutmicrobiotainterventionswithclostridiumbutyricumandnorfloxacinmodulateimmuneresponseinexperimentalautoimmuneencephalomyelitismice
AT maxiaomeng gutmicrobiotainterventionswithclostridiumbutyricumandnorfloxacinmodulateimmuneresponseinexperimentalautoimmuneencephalomyelitismice
AT liuyingying gutmicrobiotainterventionswithclostridiumbutyricumandnorfloxacinmodulateimmuneresponseinexperimentalautoimmuneencephalomyelitismice
AT malili gutmicrobiotainterventionswithclostridiumbutyricumandnorfloxacinmodulateimmuneresponseinexperimentalautoimmuneencephalomyelitismice
AT chenzhaoyu gutmicrobiotainterventionswithclostridiumbutyricumandnorfloxacinmodulateimmuneresponseinexperimentalautoimmuneencephalomyelitismice
AT linxiuli gutmicrobiotainterventionswithclostridiumbutyricumandnorfloxacinmodulateimmuneresponseinexperimentalautoimmuneencephalomyelitismice
AT silei gutmicrobiotainterventionswithclostridiumbutyricumandnorfloxacinmodulateimmuneresponseinexperimentalautoimmuneencephalomyelitismice
AT maxueying gutmicrobiotainterventionswithclostridiumbutyricumandnorfloxacinmodulateimmuneresponseinexperimentalautoimmuneencephalomyelitismice
AT chenxiaohong gutmicrobiotainterventionswithclostridiumbutyricumandnorfloxacinmodulateimmuneresponseinexperimentalautoimmuneencephalomyelitismice